New York State Psychiatric Institute
New York, 10032, United States
Location status: Recruiting
Location contact
Joanna Steinglass, MD
CONTACT
Joanna Steinglass, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT04810624
This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package.
In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after acute hospitalization. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Not applicable
New York, 10032, United States
Location status: Recruiting
Joanna Steinglass, MD
CONTACT
Joanna Steinglass, MD
PRINCIPAL_INVESTIGATOR
While many approaches to reducing relapse after hospital care have been tried, there is little information about which treatment elements confer benefit. This trial, Relapse Prevention and Changing Habits (REACH+), targets the habitual control of maladaptive behavior to support patients with AN in the 6 months after acute treatment, a time of high vulnerability to relapse. Each component of REACH+ addresses a question that is critical to answer in order to identify and optimize a relapse prevention treatment package that balances efficacy and burden. We will test the acceptability and feasibility of 5 components that together target habits: 1) Behavioral, 2) Cognitive, 3)Motivation, 4) Food Monitoring, and 5) Skill Consolidation. In the Preparation Phase, 10 participants were enrolled, and accessibility and feasibility of the treatment package was examined. The current Optimization Phase includes a finalized treatment manual (including an online platform) and will test each component's contribution to weight maintenance after acute treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Psychotherapy
Time frame: 6-month end of treatment
Measured via rate of weight loss (in lbs) following discharge from inpatient unit
Time frame: 6-month end of treatment
Measured via Self-Report Habit Index (SRHI)
Time frame: 6-month end of treatment
Measured via Eating Disorder Examination, Questionnaire Version (EDE-Q)
Time frame: 6-month end of treatment
Measured via General Self-Efficacy Scale (GSES)
Time frame: 6-month end of treatment
Measured via Food Choice Task
Time frame: 6-month end of treatment
Measured via platform utilization time
Contact information is provided by the study sponsor or research team.
New York State Psychiatric Institute
Other
Optimizing Relapse Prevention and Changing Habits in Anorexia Nervosa
Acronym: REACH+
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07600671
Anorexia Nervosa, Binge Eating Disorder
Lebanon, New Hampshire, United States
View Trial DetailsNCT05918835
Anorexia Nervosa, Feeding and Eating Disorders
New York, United States
View Trial DetailsNCT06594913
Anorexia Nervosa, Avoidant Restrictive Food Intake Disorder
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05763849
Anorexia Nervosa, Feeding and Eating Disorders
New York, United States
View Trial Details